Galapagos NV (GXEA) - Total Liabilities

Latest as of September 2025: €1.06 Billion EUR ≈ $1.25 Billion USD

Based on the latest financial reports, Galapagos NV (GXEA) has total liabilities worth €1.06 Billion EUR (≈ $1.25 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GXEA cash generation efficiency to assess how effectively this company generates cash.

Galapagos NV - Total Liabilities Trend (2016–2024)

This chart illustrates how Galapagos NV's total liabilities have evolved over time, based on quarterly financial data. Check Galapagos NV (GXEA) asset resilience to evaluate the company's liquid asset resilience ratio.

Galapagos NV Competitors by Total Liabilities

The table below lists competitors of Galapagos NV ranked by their total liabilities.

Company	Country	Total Liabilities
Ora Banda Mining Ltd AU:OBM	Australia	AU$180.21 Million
Grupo Gigante S. A. B. de C. V MX:GIGANTE	Mexico	MX$26.66 Billion
Bikaji Foods International Limited NSE:BIKAJI	India	Rs5.99 Billion
Tyra Biosciences Inc NASDAQ:TYRA	USA	$23.43 Million
Harmony Biosciences Holdings NASDAQ:HRMY	USA	$373.10 Million
Malaysian Pacific Industries KLSE:3867	Malaysia	RM690.97 Million
LTC Properties Inc NYSE:LTC	USA	$999.17 Million
Akr Corporindo Tbk JK:AKRA	Indonesia	Rp20.95 Trillion

Liability Composition Analysis (2016–2024)

This chart breaks down Galapagos NV's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Galapagos NV market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.63	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.44	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Galapagos NV's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Galapagos NV (2016–2024)

The table below shows the annual total liabilities of Galapagos NV from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	€1.24 Billion ≈ $1.45 Billion	-20.68%
2023-12-31	€1.56 Billion ≈ $1.83 Billion	-29.28%
2022-12-31	€2.21 Billion ≈ $2.58 Billion	-13.39%
2021-12-31	€2.55 Billion ≈ $2.98 Billion	-16.33%
2020-12-31	€3.05 Billion ≈ $3.56 Billion	-4.56%
2019-12-31	€3.19 Billion ≈ $3.73 Billion	+1317.53%
2018-12-31	€225.25 Million ≈ $263.34 Million	-17.88%
2017-12-31	€274.29 Million ≈ $320.68 Million	-15.51%
2016-12-31	€324.64 Million ≈ $379.53 Million	--

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$1.83 Billion

€1.57 Billion EUR

Market Cap Rank

#6600 Global

#963 in Germany

Share Price

€23.80

Change (1 day)

-1.65%

52-Week Range

€22.40 - €31.40

All Time High

€246.00